Combined photodynamic therapy with systemic chemotherapy for unresectable cholangiocarcinoma
Open Access
- 13 January 2019
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 49 (4) , 437-447
Abstract
Summary: Background: Chemotherapy with gemcitabine and cisplatin is the current standard for patients with unresectable cholangiocarcinoma. Local photodynamic therapy has also demonstrated benefit in patients with extrahepatic cholangiocarcinoma.Aim: To evaluate the benefit of photodynamic therapy in combination with systemic chemotherapy in advanced extrahepatic cholangiocarcinoma.Methods: Three hundred and fifty‐three patients diagnosed with cholangiocarcinoma between 2004 and 2016 were treated at the University Hospital of Bonn, Germany. Of these, 96 suffering from unresectable extrahepatic cholangiocarcinoma were included. Patients were stratified according to treatment: combination photodynamic therapy and chemotherapy (36 patients), photodynamic therapy alone (34 patients), and chemotherapy alone (26 patients).Results: Combined photodynamic therapy with chemotherapy resulted in significantly longer overall survival than chemotherapy alone (P = 0.022). Median survival was 20 months in the combination group (95% CI: 16.38‐23.62), 15 months in the photodynamic alone group (95% CI: 10.02‐19.98) and 10 months in the chemotherapy alone group (95% CI: 8.45‐11.55). In multivariate analysis, combination therapy and photodynamic therapy alone (HR: 0.41, 95% CI: 0.22‐0.77, P = 0.006), metal stenting, and radiofrequency ablation were independent predictors of longer survival.Conclusions: Combination photodynamic therapy and chemotherapy was well tolerated and resulted in significantly longer survival than chemotherapy alone. Application of photodynamic therapy significantly correlated with longer survival, demonstrating benefit in advanced cholangiocarcinoma. Thus, photodynamic therapy should be considered during therapeutic decision making in advanced cholangiocarcinoma.Keywords
Funding Information
- Deutsche Krebshilfe
This publication has 17 references indexed in Scilit:
- Long-Term Outcome of Photodynamic Therapy with Systemic Chemotherapy Compared to Photodynamic Therapy Alone in Patients with Advanced Hilar CholangiocarcinomaGut and Liver, 2014
- Randomised phase II trial of photodynamic therapy plus oral fluoropyrimidine, S-1, versus photodynamic therapy alone for unresectable hilar cholangiocarcinomaEuropean Journal of Cancer, 2014
- Pathogenesis, Diagnosis, and Management of CholangiocarcinomaGastroenterology, 2013
- Combination of Conservative and Interventional Therapy Strategies for Intra- and Extrahepatic Cholangiocellular Carcinoma: A Retrospective Survival AnalysisGastroenterology Research and Practice, 2011
- Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in JapanBritish Journal of Cancer, 2010
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract CancerNew England Journal of Medicine, 2010
- CholangiocarcinomaAnnals of Surgery, 2007
- Surgical and Palliative Management and Outcome in 184 Patients With Hilar CholangiocarcinomaAnnals of Surgery, 2006
- Photodynamic therapy and anti-tumour immunityNature Reviews Cancer, 2006
- Prospective Study of the Effectiveness of Percutaneous Transhepatic Photodynamic Therapy for Advanced Bile Duct Cancer and the Role of Intraductal Ultrasonography in Response AssessmentEndoscopy, 2005